LUMIRADX LTD - *W EXP 09/28/202 (LMDWF)

CUSIP: G5709L117

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / *W EXP 09/28/202
Total 13F shares
6,075,926
Share change
+1,650
Total reported value
$2,590,672
Price per share
$0.03
Number of holders
12
Value change
+$49
Number of buys
2

Quarterly Holders Quick Answers

What is CUSIP G5709L117?
CUSIP G5709L117 identifies LMDWF - LUMIRADX LTD - *W EXP 09/28/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LUMIRADX LTD - *W EXP 09/28/202 (LMDWF) as of Q2 2023

As of 30 Jun 2023, LUMIRADX LTD - *W EXP 09/28/202 (LMDWF) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,075,926 shares. The largest 10 holders included CVS HEALTH Corp, Balyasny Asset Management L.P., LMR Partners LLP, KIM, LLC, MMCAP International Inc. SPC, Walleye Capital LLC, Covalent Partners LLC, WOLVERINE ASSET MANAGEMENT LLC, Walleye Trading LLC, and Ancora Advisors, LLC. This page lists 12 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.